Rani Therapeutics Holdings, Inc. (RANI)
NASDAQ: RANI · Real-Time Price · USD
0.868
-0.022 (-2.46%)
At close: Apr 28, 2026, 4:00 PM EDT
0.870
+0.002 (0.23%)
After-hours: Apr 28, 2026, 7:57 PM EDT
RANI Employees
As of December 31, 2025, Rani Therapeutics Holdings had 71 total employees, including 69 full-time and 2 part-time employees. The number of employees decreased by 35 or -33.02% compared to the previous year.
Employees
71
Change (1Y)
-35
Growth (1Y)
-33.02%
Revenue / Employee
$23,000
Profits / Employee
-$417,930
Market Cap
86.64M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Inovio Pharmaceuticals | 112 |
| Fractyl Health | 100 |
| PolyPid | 75 |
| eXoZymes | 32 |
| Q32 Bio | 24 |
| NeurAxis | 24 |
| ProMIS Neurosciences | 11 |
| Aldeyra Therapeutics | 8 |
RANI News
- 19 days ago - Rani Therapeutics Appoints Dr. Sara Kenkare-Mitra as Strategic Advisor to Advance Platform and Clinical Strategy - GlobeNewsWire
- 4 weeks ago - Rani Therapeutics Holdings Earnings Call Transcript: Q4 2025 - Transcripts
- 4 weeks ago - Rani Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results; Provides Corporate Update - GlobeNewsWire
- 4 weeks ago - Rani Therapeutics Appoints Jesper Høiland as Head of Strategy to Advance Corporate and Pipeline Prioritization - GlobeNewsWire
- 5 weeks ago - Rani Therapeutics to Report Fourth Quarter and Full Year 2025 Financial Results - GlobeNewsWire
- 3 months ago - Rani Therapeutics Announces the Promotion of Alireza Javadi, Ph.D. to Chief Technical Officer - GlobeNewsWire
- 3 months ago - Rani Therapeutics Initiates Phase 1 Study of RT-114 RaniPill® for the Treatment of Obesity in Collaboration with ProGen - GlobeNewsWire
- 5 months ago - Rani Therapeutics to Participate in the Evercore Healthcare Conference - GlobeNewsWire